Sentences with phrase «vaccine research study»

I was particularly impressed with how well they chose the «roommate» assignments for the hospital stay during the malaria vaccine research study.

This HIV vaccine research study is being conducted in collaboration with Muhimbili University (MUHAS)

Other studies included use of rapid tests for HIV, HBV and HCV for emergency field testing of the «Walking Blood Bank» in military operations; use of dried blood spots for collection of specimens in the field for testing of HIV, Dengue, West Nile Virus and Chikungunya Virus; and molecular assays for monitoring Chlamydia trachomatis, Neisseria gonorrhoeae, Ebola virus, and other infectious agents in epidemiology and vaccine research studies.

Not exact matches

Among the offerings from this research organization is a patented environmental exposure chamber, which provides consistent and naturalistic levels of allergens to assist with the study of allergy medications and vaccines.

In essence, the HPV vaccine will continue to be advised against during pregnancy until more research confirms what this study has found.

In particular, much of our Division's past research has focused on vaccine studies and investigations into the cause of Kawasaki disease.

Published in The Journal of Rural Health, the study involved research nurses administering the first dose of the HPV vaccine series free of charge to Appalachian Kentucky women aged 18 - 26.

Harpal Kumar, Cancer Research UK's chief executive, said: «As someone with an ethnic minority background myself and as a parent, this study highlights a very worrying reason why girls from some minority groups don't get the HPV vaccine.

Study authors intend to perform additional research in the future to follow up on their estimate of how well the current vaccines protect against HPV - associated cancers.

Dr Alice Forster, study author and Cancer Research UK scientist at University College London, said: «Although around 87 per cent of girls in the UK do have the vaccine it's concerning to see that some girls from some ethnic minority groups feel they don't need to have it.

«Even with the new immunological studies, we can't tell what's special about the whole - cell vaccine that makes it better,» says Kathryn Edwards, the director of the Vanderbilt University School of Medicine Vaccine Research vaccine that makes it better,» says Kathryn Edwards, the director of the Vanderbilt University School of Medicine Vaccine Research Vaccine Research Center.

The study offers more precise evidence that the earlier pertussis vaccine was superior to the current one, building on previous research that had already shown that the newer vaccine's effectiveness wanes sooner than expected.

«Based on epidemiological studies, the 9vHPV vaccine could prevent approximately 90 percent of cervical cancer, 90 percent of HPV - related vulvar and vaginal cancer, 70 to 85 percent of high - grade cervical disease in females, and approximately 90 percent of HPV - related anal cancer and genital warts in males and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Moffitt.

For their research, Pekosz and his team, using human nasal tract cells, studied the weakened strain of the flu virus that is used in the nasal spray vaccine and compared its behavior with that of the flu virus itself.

The research team is planning a new study to further examine the acellular vaccine's effectiveness.

The organization supports vaccine - related research, and Singer knew that her bosses would expect her to vote for more studies of vaccines as a possible cause of the condition.

«We are pleased to have demonstrated such a potent and durable immune response to the vaccine,» said the study's lead author, Sita Awasthi, PhD, a research associate professor of Infectious Diseases at Penn. «If found effective in clinical trials, the vaccine will have a huge impact on reducing the overall prevalence of genital herpes infections and could reduce new HIV infections as well, especially in high - burden regions of sub-Saharan Africa.»

But influenza vaccine research completed before that time by Yoshihiro Kawaoka's group at the University of Wisconsin, Madison, may demonstrate «the risk of curtailing so - called [GOF] studies,» wrote Jon Cohen in a Wednesday ScienceInsider.

The multi-center study enrolled 31,989 participants from 126 research centers in the U.S. and Canada during the 2011 - 2012 and 2012 - 2013 influenza seasons in the Northern Hemisphere in order to compare the high - dose trivalent vaccine versus the standard - dose trivalent vaccine in adults over 65 years of age.

The new research is at odds with other studies that cleared the vaccine of responsibility.

By studying healthy people, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center, part of the NIH, and colleagues from King's College London have created a reference resource for other scientists.

«If this research is borne out in future studies, we could be less than a decade away from a safe and effective live - attenuated vaccine for RSV.»

One goal of the study is to demonstrate the prevalence of H. influenzae in the region, explains Joel Ward, director of the Center for Vaccine Research at the University of California, Los Angeles, and scientific adviser to IVI.

«An RSV vaccine with this M2 - 2 deletion could tip the balance toward a better immune response, which is what we predicted based on earlier laboratory studies,» says study leader Ruth A. Karron, MD, director of the Center for Immunization Research and a professor in the Department of International Health at the Bloomberg School.

«Given the key similarities to human infections, a marmoset model of Zika may be useful for testing of new drug and vaccines,» said Texas Biomedical Research Institute virologist Jean Patterson, Ph.D. «Having an animal model of Zika infection to study may help us identify places where we might be able to block transmission.»

For the study, the research team used a new method in which mice were immunized with a model vaccine (called an antigen) that is given orally.

The European research collaboration behind this study focuses on deep immunological analysis of the immunogenicity and reactogenicity of the Ebola vaccine in healthy volunteers.

Kang's primary research focuses on designing and developing effective vaccines against viral diseases such as influenza virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to study if ginseng can be used to improve health and protect against disease because of the potential benefit in fighting these viruses.

The winners of the prize are Maged Al - Sherbiny from Egypt, for his research on vaccines and diagnostics against hepatitis C and schistosomiasis; plant scientist Felix Dapare Dakora from Tshwane University of Technology, Pretoria, in South Africa for his work on legumes and soil bacteria; and Rossana Arroyo of the Centre for Research and Advanced Studies of Mexico's National Polytechnic Institute, who studies trichomoniasis, a parasitic research on vaccines and diagnostics against hepatitis C and schistosomiasis; plant scientist Felix Dapare Dakora from Tshwane University of Technology, Pretoria, in South Africa for his work on legumes and soil bacteria; and Rossana Arroyo of the Centre for Research and Advanced Studies of Mexico's National Polytechnic Institute, who studies trichomoniasis, a parasitic Research and Advanced Studies of Mexico's National Polytechnic Institute, who studies trichomoniasis, a parasitic dStudies of Mexico's National Polytechnic Institute, who studies trichomoniasis, a parasitic dstudies trichomoniasis, a parasitic disease.

The Walter Reed Army Institute of Research (WRAIR) and collaborators at the Beth Israel Deaconess Medical Center and Harvard Medical School have completed a promising preclinical study of two Zika vaccine candidates that suggests that an effective human vaccine will be achievable.

In an effort to provide broad protection against meningitis, the researchers are now developing a vaccine that would prevent the bacteria from recognizing the laminin receptor, according to Elaine Tuomanen, a leader of the study and a physician at St. Jude Children's Research Hospital in Memphis, Tennessee.

They have become a valuable resource for biologists, enabling momentous scientific breakthroughs including the development of the polio vaccine the Nobel Prize winning studies defining the role of telomerase in aging, and research on the causative role of human papillomavirus (HPV) in some types of cervical cancer.

«This is an important demonstration of the possibilities opened up for immunotherapy by DMAb technology to direct in vivo production of antibodies of major relevance to human cancer,» said David B. Weiner, Ph.D., executive vice president of The Wistar Institute, director of The Wistar Institute Vaccine & Immunotherapy Center, W.W. Smith Charitable Trust Professor in Cancer Research, and senior author of the study.

The work, directed by researchers at St. Jude Children's Research Hospital in Memphis, Tenn., found that some study participants who reported receiving flu vaccines had a strong immune response not only against the seasonal H3N2 flu strain from 2010, when blood samples were collected for analysis, but also against flu subtypes never included in any vaccine formulation.

The Lancet and most of the article's coauthors ultimately disowned the study because its lead author had not divulged that he was also being paid to conduct research for parents seeking to sue vaccine manufacturers.

«Taken together, these two studies suggest that the new scalable vaccine formulation is likely to prove as effective as the original formulation — which would make it the first protective TB vaccine in humans since BCG, which was introduced almost a century ago,» said Professor Ajit Lalvani, Director of the Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London and a member of the DAR - 901 development team.

The work and other similar, recent studies could also help «redefine» how vaccines are developed to make them more effective and less likely to have side effects, says Wayne Koff, the chief scientific officer at the International AIDS Vaccine Initiative in New York City, who was not involved with the research.

He said that prior research has shown that it is very hard to completely debunk misinformation, such as the mistaken belief that the MMR vaccine causes autism, but the study results suggest that accurately communicating about the risks of Zika can help lessen the detrimental effects of the misbelief.

«We have dozens of studies examining autism and vaccines, and they don't show a link,» says Alison Singer, president of the Autism Science Foundation, a nonprofit that supports autism research.

«Uncovering the process by which neutralizing antibodies develop is critical to HIV vaccine design,» said Elise Landais, Senior Research Scientist with IAVI and lead author of the study.

The immunological benefits from the wild mice's gut bacteria may, in part, explain a persistent problem in disease research: Why disease experiments in lab mice, such as vaccine studies, turn out very differently in humans or other animals.

A study led by St. Jude Children's Research Hospital identifies new path to a universal influenza vaccine emphasizing production of broadly specific antibodies that target multiple flu viruses

The HVTN 100 study is part of a larger HIV vaccine research endeavor led by a group called the Pox - Protein Public - Private Partnership, or the P5 — a diverse set of public and private organizations, including MHRP, committed to building on the success of RV144.

The Pilot Bioproduction Facility at WRAIR manufactured the ZPIV vaccine being used in Phase 1 clinical studies, and the Army recently signed a cooperative research and development agreement to transfer the ZPIV technology to Sanofi Pasteur to explore larger scale manufacturing and advanced development.

This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program - led RV144 clinical trial in Thailand — the first study to demonstrate that a vaccine can protect people from HIV infection.

The JCVI GCID aims to study pathogens and the genetic determinants of their virulence, drug - resistance, immune evasion and interactions with the host, and host microbiome to advance research in pathogenicity, drug - resistance, disease transmission and vaccine development.

We have focused our bioinformatics research efforts on the study of host - pathogen interactions (HPI) and vaccines against infectious diseases.

According to Col Jerome Kim, Walter Reed Army Institute of Research, US, who was also part of the lead group for the study, apart from the current four doses of vaccines that were given to subjects in the phase III clinical trials in Thailand, they are planning to give a booster does after six months to increase the strength of the vaccine.

In the 1880s, these studies shifted focus; the field of immunology was born (from research conducted by Louis Pasteur, at the University of Strasbourg, and Robert Koch, as a medical officer in Poland) and many researchers focused on creating vaccines to cure diseases.

Results from an initial study to ensure that the RV144 vaccine regimen is safe and well - tolerated in South African volunteers were reported at the 2014 HIV Research for Prevention (R4P) conference.